Retrospective Study of the Linear™ Hip
Terminated
- Conditions
- OsteoarthritisCorrection of a Functional DeformityRheumatoid ArthritisAvascular NecrosisFemoral Fracture
- Registration Number
- NCT00764959
- Lead Sponsor
- Encore Medical, L.P.
- Brief Summary
The purpose of this study is to evaluate the use and efficacy of the Encore Linear™ Hip System in a group of 200 patients for whom data has already been collected.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
-
Have hip joint disease related to one or more of the following
- osteoarthritis
- rheumatoid arthritis
- femoral fracture
- correction of a functional deformity
- avascular necrosis of the natural femoral head
-
Skeletal maturity
-
Patient is likely to be available for evaluation for the duration of the study
-
Able and willing to sign the informed consent and follow study procedures
-
Patient is not pregnant
-
No infection present
-
No known materials sensitivity
-
Patient is over 18 years of age
Exclusion Criteria
- Skeletal immaturity
- Infection or sepsis
- Insufficient bone quality that may affect the stability of the implant
- Muscular, neurologic or vascular deficiencies which compromise the affected extremity
- Alcoholism or other addictions
- Prisoners
- High levels of physical activity
- Patient is pregnant
- Loss of ligamentous structures
- Materials sensitivity
- Patient is under 18 years of age
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The use and efficacy of the Encore Linear™ Hip System 2 year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hussamy Orthopedics
🇺🇸Vero Beach, Florida, United States
Hussamy Orthopedics🇺🇸Vero Beach, Florida, United States